Valencia Nutrition discloses insider trading by three insiders
- Jay Jatin Shah, Whole-Time Director & CFO, disposed of 18,000 equity shares on September 25, 2026, for Rs. 10,80,000/-, reducing his holding to 1,99,000 shares (0.096%)
- Ashish Narendra Kamdar, Additional Director (appointed September 03, 2026), acquired 3000 equity shares for Rs. 1,80,000/- on market
- Lajja Ashish Kamdar, wife of the Additional Director, acquired 15,000 equity shares for Rs. 9,00,000/-, representing 0.008% of shareholding post acquisition
- All disclosures were filed on September 29, 2026, under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
- No derivative transactions were reported by any of the three insiders

*this image is generated using AI for illustrative purposes only.
Valencia Nutrition Limited filed disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, on September 29, 2026, covering share transactions by three insiders across separate filings submitted to BSE Limited.
Share disposal by Whole-Time Director & CFO
Jay Jatin Shah, Whole-Time Director & CFO, disposed of 18,000 equity shares on September 25, 2026, through an on-market transaction valued at Rs. 10,80,000/-. Prior to the disposal, Shah held 207800 equity shares. Following the transaction, his holding stood at 1,99,000 equity shares, representing 0.096% of the company's shareholding. The company received the disclosure on September 28, 2026.
| Parameter | Details |
|---|---|
| Name | Jay Jatin Shah |
| Designation | Whole-Time Director & CFO |
| Transaction type | Sale |
| Securities type | Equity shares |
| Shares disposed | 18,000 |
| Transaction value | Rs. 10,80,000/- |
| Shares held prior | 207800 |
| Shares held post | 1,99,000 |
| Post-transaction shareholding | 0.096% |
| Date of transaction | September 25, 2026 |
| Mode | On Market |
Acquisition by Additional Director
Ashish Narendra Kamdar, Additional Director, acquired 3000 equity shares through an on-market purchase valued at Rs. 1,80,000/-. Kamdar was appointed as Additional Director on September 03, 2026, and held zero equity shares at the time of appointment. The company received his disclosure on September 28, 2026.
| Parameter | Details |
|---|---|
| Name | Ashish Narendra Kamdar |
| Designation | Additional Director |
| Date of appointment | September 03, 2026 |
| Transaction type | Purchase of Shares |
| Securities type | Equity |
| Shares acquired | 3000 |
| Transaction value | Rs. 1,80,000/- |
| Shares held at appointment | 0 |
| Shareholding at appointment | 0.00% |
| Mode | On Market |
Acquisition by wife of Additional Director
Lajja Ashish Kamdar, wife of the Additional Director, acquired 15,000 equity shares on September 25, 2026, through an on-market transaction valued at Rs. 9,00,000/-. Her post-acquisition holding stood at 15,000 equity shares, representing 0.008% of the company's shareholding. She held zero shares prior to the acquisition. The company received her disclosure on September 28, 2026.
| Parameter | Details |
|---|---|
| Name | Lajja Ashish Kamdar |
| Category | Wife of Additional Director |
| Transaction type | Purchase |
| Securities type | Equity |
| Shares acquired | 15,000 |
| Transaction value | Rs. 9,00,000/- |
| Shares held post acquisition | 15,000 |
| Post-acquisition shareholding | 0.008% |
| Date of transaction | September 25, 2026 |
| Mode | On Market |
Regulatory context
All three disclosures were submitted by Manish Turakhia, Managing Director of Valencia Nutrition Limited, pursuant to Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. No derivative transactions were reported by any of the three insiders in the respective filings. The disclosures were addressed to the Department of Corporate Services, BSE Limited.
Historical Stock Returns for Valencia Nutrition
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | +10.09% | +27.66% | 0.0% | 0.0% |
Will the CFO's share disposal signal a broader trend of insider selling or indicate personal liquidity needs ahead of upcoming earnings?
How might the immediate equity acquisition by the newly appointed Additional Director and his family influence investor confidence in the company's strategic direction?
Are there any pending corporate actions or board decisions that could explain the simultaneous buying by new directors and selling by the CFO on the same date?


































